Xuan Sha

Nanjing, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Corrigendum to "Mitochondria-targeted manganese-based mesoporous silica nanoplatforms trigger cGAS-STING activation and sensitize anti PD-L1 therapy in triple-negative breast cancer" [Acta Biomaterialia 199 (2025) 374-386].

Corrigendum to "Mitochondria-targeted manganese-based mesoporous silica nanoplatforms trigger cGAS-STING activation and sensitize anti PD-L1 therapy in triple-negative breast cancer" [Acta Biomaterialia 199 (2025) 374-386].

Journal: Acta biomaterialia

Published: January 19, 2026

Dentate nucleus signal changes after multiple GBCAs MRI in breast cancer patients: A generalized additive model retrospective study.

Dentate nucleus signal changes after multiple GBCAs MRI in breast cancer patients: A generalized additive model retrospective study.

Journal: Magnetic resonance imaging

Published: January 15, 2026

Repetitive transcranial magnetic stimulation for nicotine addiction: A regional homogeneity study based on resting-state fMRI.

Repetitive transcranial magnetic stimulation for nicotine addiction: A regional homogeneity study based on resting-state fMRI.

Journal: Psychiatry research. Neuroimaging

Published: May 27, 2025

Multifunctional glycyrrhizic acid-loaded nanoplatform combining ferroptosis induction and HMGB1 blockade for enhanced tumor immunotherapy.

Multifunctional glycyrrhizic acid-loaded nanoplatform combining ferroptosis induction and HMGB1 blockade for enhanced tumor immunotherapy.

Journal: Journal of nanobiotechnology

Published: February 27, 2025

Mitochondria-targeted manganese-based mesoporous silica nanoplatforms trigger cGAS-STING activation and sensitize anti PD-L1 therapy in triple-negative breast cancer.

Mitochondria-targeted manganese-based mesoporous silica nanoplatforms trigger cGAS-STING activation and sensitize anti PD-L1 therapy in triple-negative breast cancer.

Journal: Acta biomaterialia

Published: January 23, 2025

Outer Membrane Vesicle-Cancer Hybrid Membrane Coating Indocyanine Green Nanoparticles for Enhancing Photothermal Therapy Efficacy in Tumors.

Outer Membrane Vesicle-Cancer Hybrid Membrane Coating Indocyanine Green Nanoparticles for Enhancing Photothermal Therapy Efficacy in Tumors.

Journal: ACS biomaterials science & engineering

Published: November 25, 2024

Pro-efferocytic macrophage membrane biomimetic nanoparticles for the synergistic treatment of atherosclerosis via competition effect.

Pro-efferocytic macrophage membrane biomimetic nanoparticles for the synergistic treatment of atherosclerosis via competition effect.

Journal: Journal of nanobiotechnology

Published: September 02, 2022

Targeted Therapy of Atherosclerosis Vulnerable Plaque by ROS-Scavenging Nanoparticles and MR/Fluorescence Dual-Modality Imaging Tracing.

Targeted Therapy of Atherosclerosis Vulnerable Plaque by ROS-Scavenging Nanoparticles and MR/Fluorescence Dual-Modality Imaging Tracing.

Journal: International journal of nanomedicine

Published: April 22, 2022

DNA aptamer-based dual-responsive nanoplatform for targeted MRI and combination therapy for cancer.

DNA aptamer-based dual-responsive nanoplatform for targeted MRI and combination therapy for cancer.

Journal: RSC advances

Published: November 15, 2021

Theranostic nanoplatform to target macrophages enables the inhibition of atherosclerosis progression and fluorescence imaging of plaque in ApoE(-/-) mice.

Theranostic nanoplatform to target macrophages enables the inhibition of atherosclerosis progression and fluorescence imaging of plaque in ApoE(-/-) mice.

Journal: Journal of nanobiotechnology

Published: May 18, 2021

The Opportunities and Challenges of Silica Nanomaterial for Atherosclerosis.

The Opportunities and Challenges of Silica Nanomaterial for Atherosclerosis.

Journal: International journal of nanomedicine

Published: November 05, 2020

Showing 1-11 of 11

Last Updated: 09/26/2026